Profile
Yi Liang served as Vice President-Oncology at Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd.
and Vice President at AstraZeneca Pharmaceuticals Co., Ltd.
Prior to that, he was the Chief Commercial Officer & President-Greater China at Zai Lab Ltd.
from 2018 to 2024.
Dr. Liang holds an MBA from China Europe International Business School and a doctorate from Fudan University.
Former positions of Yi Liang
| Companies | Position | End |
|---|---|---|
| ZAI LAB LIMITED | Corporate Officer/Principal | 29/04/2024 |
| Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd. | Corporate Officer/Principal | - |
AstraZeneca Pharmaceuticals Co., Ltd.
 AstraZeneca Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca Pharmaceutical Co., Ltd. is a Chinese global biopharmaceutical company driven by innovation. Based in Shanghai, China. The private company believes in the power of science and considers it a top priority in all of its work. | Corporate Officer/Principal | - |
Training of Yi Liang
| China Europe International Business School | Masters Business Admin |
| Fudan University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ZAI LAB LIMITED | Health Technology |
| Private companies | 2 |
|---|---|
| Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd. | |
AstraZeneca Pharmaceuticals Co., Ltd.
AstraZeneca Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca Pharmaceutical Co., Ltd. is a Chinese global biopharmaceutical company driven by innovation. Based in Shanghai, China. The private company believes in the power of science and considers it a top priority in all of its work. | Health Technology |
- Stock Market
- Insiders
- Yi Liang
